Evidence map›Paper›PMID 17543117›Full record

ArticleBMC evolutionary biology2007

Distinguishing importation from diversification of quinolone-resistant Neisseria gonorrhoeae by molecular evolutionary analysis.

Marcos Pérez-Losada, Keith A Crandall, Margaret C Bash, Michael Dan, Jonathan Zenilman, Raphael P Viscidi

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC evolutionary biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Gonorrhea - an evolving disease of the new millennium.Microbial cell (Graz, Austria) · 2016
    Review
  4. Article
  5. Article
  6. Article
  7. The evolution of HIV: inferences using phylogenetics.Molecular phylogenetics and evolution · 2012
    Review
  8. Global fluoroquinolone resistance epidemiology and implictions for clinical use.Interdisciplinary perspectives on infectious diseases · 2012
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Marcos Pérez-LosadaDepartment of Integrative Biology, Brigham Young University, Provo, UT, USA. mlosada@genoma-llc.com <mlosada@genoma-llc.com>
Keith A Crandall
Margaret C Bash
Michael Dan
Jonathan Zenilman
Raphael P Viscidi
Brigham Young University · USCenter for Biologics Evaluation and Research · USGenomatica (United States) · USJohns Hopkins Medicine · USStanley Foundation · USWolfson Medical Center · IL

Funding

Molecular Epidemiology of N. gonorrhoeaeR01AI050217 · NIAID · JOHNS HOPKINS UNIVERSITY · PI VISCIDI, RAPHAEL PAUL · 2002 to 2006
$2.6M
NIAID NIH HHS R01 AI050217NIAID NIH HHS R01-AI-50217
6 · The paper itself

Abstract

backgroundDistinguishing the recent introduction of quinolone resistant gonococci into a population from diversification of resistant strains already in the population is important for planning effective infection control strategies. We applied molecular evolutionary analyses to DNA sequences from 9 housekeeping genes and gyrA, parC and porB of 24 quinolone resistant N. gonorrhoeae (QRNG) and 24 quinolone sensitive isolates collected in Israel during 2000-2001.

resultsPhylogenetic and eBURST analyses and estimates of divergence time indicated QRNG were introduced on 3 separate occasions and underwent limited diversification by mutation, deletion and horizontal gene transfer. Reconstruction of N. gonorrhoeae demography showed a slowly declining effective strain population size from 1976 to 1993, rapid decline between 1994 and 1999, and an increase from 1999 to 2001. This is partially attributable to declining gonorrhea case rates from 1973 to 1994. Additional contributing factors are selective sweeps of antibiotic resistant gonococci and increased transmission from sex workers. The abrupt decline in the mid-1990s heralded an increased incidence of gonorrhea from 1997 to the present. The subsequent increase in effective strain population size since 1999 reflects the increased gonococcal census population and introduction of quinolone resistance strains.

conclusionOur study demonstrates the effective use of population genetic approaches to assess recent and historical population dynamics of N. gonorrhoeae.

Indexed as

Evolution, MolecularGenetics, PopulationPhylogenyQuinolonesBase SequenceBayes TheoremDrug Resistance, BacterialGenes, BacterialGonorrheaHumansModels, GeneticMolecular Sequence DataNeisseria gonorrhoeaePopulation DynamicsSequence Analysis, DNAQuinolones

Identifiers

PMID17543117
PMCPMC1906744
OpenAlexW1971456267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.